After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.

Select Publications and Abstracts

Analytical validation of a novel circulating tumor DNA detection platform for targeted and immunotherapy selection; AACR Annual Meeting, 2018

Pratyush Gupta, Julian Lucas, Alex Atkins, Wen-Sy Tsai, Twinkal Marfatia, Shih-En Chang, Oscar Segurado, Rui Mei

CTC and ctDNA profiling to detect 6 NCCN-guideline recommended classes of alterations for immunotherapy and targeted therapy selection using sample from a single blood draw; AACR Annual Meeting, 2018

Huangpin B. Hsieh, Jen-Chia Wu, Feng-Ming Lin, Julian Lucas, Alex Atkins, Pratyush Gupta, Hung-Jen Shao, Yen-Lin Chen, Wen-Jie Huang, Chia-Hsun Hsieh, Ruey Kuen Hsieh, Kuo-Wei Chen, Ming-Hong Yen, Mana Javey, Shih-En Chang, Twinkal Marfatia, Drew Watson, Mahul Amin, Ashish Nimgaonkar, Oscar Segurado, Rui Mei

CSF-ctDNA SMSEQ Analysis to Tailor the Treatment of a Patient with Brain Metastases: A Case Report; Case Reports in Oncology, 2018

Wen-Tsung Huang, Na-Mi Lu, Wen-Yuan Hsu, Shih-En Chang, Alex Atkins, Rui Mei, Manana Javey

Prospective Clinical Study of Circulating Tumor Cells For Colorectal Cancer Screening; ASCO Gastrointestinal Cancers Symposium 2018

WenSy Tsai, Ashish Nimgaonkar, Oscar Segurado, Ying Chang, Ben Hsieh, Hung-Jen Shao, Jen-Chia Wu, Jr-Ming Lai, Mana Javey, Drew Watson, Rui Mei

See-Tong Pang, Ying-Hsu Chang, Po-Hung Lin, Ying Chang, Drew Watson, Oscar Segurado, Si-Hong Lu, Jen-chia Wu, Jr-Ming Lai, Hung-Jen Shao, Shih-En Chang, Ben Hsieh, Mana Javey, Rui Mei

Liquid Biopsy Prevents Inaccurate Her2 Status Determination by in situ Hybridization in a Patient with Invasive Ductal Adenocarcinoma of the Breast: Case Report

Yen-Dun Tony Tzeng, Shih-En Chang, Rui Mei, Manana Javey

Identifying Cancer Origin Using Circulating Tumor Cells, Cancer Biology and Therapy 2016

Si-Hong Lu, Wen-Sy Tsai, Ying-Hsu Chang, Teh-Ying Chou, See-Tong Pang, Po-Hung Lin, Chun-Ming Tsai, Ying-Chih Chang

Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients, Nature Scientific Reports 2016

Wen-Sy Tsai, Jinn-Shiun Chen, Hung-Jen Shao, Jen-Chia Wu, Jr-Ming Lai, Si-Hong Lu, Tsung-Fu Hung, Yen-Chi Chiu, Jeng-Fu You, Pao-Shiu Hsieh, Chien-Yuh Yeh, Hsin-Yuan Hung, Sum-Fu Chiang, Geng-Ping Lin, Reiping Tang, Ying-Chih Chang

Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection, PLOS 2016

Jia-Yang Chen , Wen-Sy Tsai , Hung-Jen Shao , Jen-Chia Wu , Jr-Ming Lai , Si-Hong Lu , Tsung-Fu Hung , Chih-Tsung Yang , Liang-Chun Wu , Jinn-Shiun Chen , Wen-Hwa Lee , Ying-Chih Chang

Genomic Profiling of Tumors Using Liquid Biopsy to Match Patients to Best Treatment Options, TJCC 2016

Wen-Sy Tsai, Shan-Fu Wu, Julian Lucas, Gangwu Mei, Mana Javey, Rui Mei

An Innovative Platform for Early Detection of Circulating Tumor Cells for Colorectal Cancer; TJCC 2016

Wen-Sy Tsai, Ying-Chih Chang, Ben Hsieh, Hung-Jen Shao, Jen-chia Wu, Jr.-Ming Lai, Mana Javey, Rui Mei

Efficient elusion of viable adhesive cells from a microfluidic system by air foam; Biomicrofluidics 2014

Jr-Ming Lai, Hung-Jen Shao, Jen-Chia Wu, Si-Hong Lu, and Ying-Chih Chang

Antibody Conjugated Supported Lipid Bilayer for Capturing and Purification of Viable Tumor Cells in Blood; Biomaterials 2013

Jen-Chia Wu, Po-Yuan Tseng Wen-Sy Tsai, Mei-Ying Liao, Si-Hong Lu, Curtis W. Frank, Jinn-Shiun Chen, Han-Chung Wu, Ying-Chih Chang

Type I Collagen-Functionalized Supported Lipid Bilayer as a Cell Culture Platform; Biomacromolecules, 2010

Chun-Jen Huang, Nam-Joon Cho, Chih-Jung Hsu, Po-Yuan Tseng, Curtis W. Frank, Ying-Chih Chang

CellMax Life

CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax’s unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.

U.S. Headquarters

1271 Oakmead Parkway Sunnyvale, CA 94085 Phone: +1 650-564-3905

Taiwan Office

18F-1 Park Street Nangkang, Taipei City (+886) 0800-555-885 (Taiwan)

© 2018 CellMax Life | All Rights Reserved | Terms and Conditions | Privacy Policy